CS211364B2 - Method of making the oxymorfone - Google Patents
Method of making the oxymorfone Download PDFInfo
- Publication number
- CS211364B2 CS211364B2 CS797115A CS711579A CS211364B2 CS 211364 B2 CS211364 B2 CS 211364B2 CS 797115 A CS797115 A CS 797115A CS 711579 A CS711579 A CS 711579A CS 211364 B2 CS211364 B2 CS 211364B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- mixture
- boron compound
- reaction
- oxycodone
- hours
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Polarising Elements (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95305678A | 1978-10-19 | 1978-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CS211364B2 true CS211364B2 (en) | 1982-02-26 |
Family
ID=25493512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS797115A CS211364B2 (en) | 1978-10-19 | 1979-10-19 | Method of making the oxymorfone |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS55501025A (fr) |
AU (1) | AU5189779A (fr) |
BE (1) | BE879494A (fr) |
CA (1) | CA1108132A (fr) |
CS (1) | CS211364B2 (fr) |
DK (1) | DK258280A (fr) |
ES (1) | ES485154A1 (fr) |
FI (1) | FI793235A (fr) |
FR (1) | FR2439201A1 (fr) |
GB (1) | GB2049680A (fr) |
IL (1) | IL58489A0 (fr) |
IT (1) | IT7969032A0 (fr) |
NL (1) | NL7920126A (fr) |
NO (1) | NO793297L (fr) |
SE (1) | SE8004454L (fr) |
WO (1) | WO1980000841A1 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4795813A (en) * | 1981-08-17 | 1989-01-03 | The Florida Board Of Regents On Behalf Of The Florida State University | Synthesis of derivatives of codeine and other 3-O-alkylmorphines |
US5668285A (en) * | 1986-10-31 | 1997-09-16 | The United States Of America As Represented By The Department Of Health And Human Services | Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates |
FR2636330B1 (fr) * | 1988-09-13 | 1990-11-30 | Sanofi Sa | Procede de preparation de derives de morphinane |
ES2129395T3 (es) * | 1989-10-16 | 1999-06-16 | Us Health | Sintesis total de enantiomeros de nortebaina, normorfina, noroximorfona y sus derivados a traves de productos intermedios n-nor. |
US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
EP1414458B1 (fr) | 2001-07-06 | 2007-04-11 | Endo Pharmaceuticals Inc. | Administration orale de 6-hydroxy-oxymorphone utilise en tant qu'analgesique |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
JP5695296B2 (ja) | 2006-03-02 | 2015-04-01 | マリンクロッド エルエルシー | 低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法 |
JP5774853B2 (ja) | 2008-01-25 | 2015-09-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 医薬投薬形 |
TWI524904B (zh) | 2008-05-09 | 2016-03-11 | 歌林達股份有限公司 | 製備醫藥用固體劑型,尤指錠劑之方法,及製備固體劑型,尤指錠劑之前驅物之方法 |
JP2012533586A (ja) | 2009-07-22 | 2012-12-27 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 酸化安定化された不正使用防止剤形 |
CA2765971C (fr) | 2009-07-22 | 2017-08-22 | Gruenenthal Gmbh | Forme galenique extrudee a chaud a liberation controlee |
NZ608865A (en) | 2010-09-02 | 2015-03-27 | Gruenenthal Chemie | Tamper resistant dosage form comprising an anionic polymer |
AU2011297901B2 (en) | 2010-09-02 | 2014-07-31 | Grunenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
PT2736497T (pt) | 2011-07-29 | 2017-11-30 | Gruenenthal Gmbh | Comprimido resistente a adulteração proporcionando libertação imediata de fármaco |
CN103841964A (zh) | 2011-07-29 | 2014-06-04 | 格吕伦塔尔有限公司 | 提供药物立即释放的抗破碎片剂 |
JP6117249B2 (ja) | 2012-02-28 | 2017-04-19 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形 |
WO2013156453A1 (fr) | 2012-04-18 | 2013-10-24 | Grünenthal GmbH | Forme pharmaceutique inviolable et résistante à la libération massive |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
MX371432B (es) | 2013-05-29 | 2020-01-30 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. |
CA2913209A1 (fr) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Forme dosifiee inviolable a profil de liberation bimodale |
MX368846B (es) | 2013-07-12 | 2019-10-18 | Gruenenthal Gmbh | Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo. |
EP3073994A1 (fr) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Préparation de composition pharmaceutique en poudre par cryo-broyage |
EP3142646A1 (fr) | 2014-05-12 | 2017-03-22 | Grünenthal GmbH | Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol |
EA201692388A1 (ru) | 2014-05-26 | 2017-05-31 | Грюненталь Гмбх | Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы |
EA035434B1 (ru) | 2015-04-24 | 2020-06-15 | Грюненталь Гмбх | Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями |
EP3346991A1 (fr) | 2015-09-10 | 2018-07-18 | Grünenthal GmbH | Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus |
ES2701855T3 (es) | 2016-05-31 | 2019-02-26 | Alcaliber Investig Desarrollo E Innovacion Slu | Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3249616A (en) * | 1966-05-03 | Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof | ||
US2806033A (en) * | 1955-08-03 | 1957-09-10 | Lewenstein | Morphine derivative |
US3775414A (en) * | 1972-05-10 | 1973-11-27 | Bristol Myers Co | Process for the preparation of 14-hydroxymorphinan derivatives |
-
1979
- 1979-10-12 NO NO793297A patent/NO793297L/no unknown
- 1979-10-18 FR FR7925895A patent/FR2439201A1/fr not_active Withdrawn
- 1979-10-18 JP JP50190279A patent/JPS55501025A/ja active Pending
- 1979-10-18 IL IL58489A patent/IL58489A0/xx unknown
- 1979-10-18 AU AU51897/79A patent/AU5189779A/en not_active Abandoned
- 1979-10-18 IT IT7969032A patent/IT7969032A0/it unknown
- 1979-10-18 WO PCT/US1979/000862 patent/WO1980000841A1/fr unknown
- 1979-10-18 BE BE0/197710A patent/BE879494A/fr unknown
- 1979-10-18 ES ES485154A patent/ES485154A1/es not_active Expired
- 1979-10-18 CA CA337,908A patent/CA1108132A/fr not_active Expired
- 1979-10-18 GB GB8014422A patent/GB2049680A/en not_active Withdrawn
- 1979-10-18 NL NL7920126A patent/NL7920126A/nl unknown
- 1979-10-18 FI FI793235A patent/FI793235A/fi not_active Application Discontinuation
- 1979-10-19 CS CS797115A patent/CS211364B2/cs unknown
-
1980
- 1980-06-16 SE SE8004454A patent/SE8004454L/xx not_active Application Discontinuation
- 1980-06-17 DK DK258280A patent/DK258280A/da unknown
Also Published As
Publication number | Publication date |
---|---|
FR2439201A1 (fr) | 1980-05-16 |
AU5189779A (en) | 1980-04-24 |
FI793235A (fi) | 1980-04-20 |
WO1980000841A1 (fr) | 1980-05-01 |
GB2049680A (en) | 1980-12-31 |
IT7969032A0 (it) | 1979-10-18 |
CA1108132A (fr) | 1981-09-01 |
JPS55501025A (fr) | 1980-11-27 |
NO793297L (no) | 1980-04-22 |
BE879494A (fr) | 1980-02-15 |
DK258280A (da) | 1980-06-17 |
SE8004454L (sv) | 1980-06-16 |
ES485154A1 (es) | 1980-06-16 |
NL7920126A (nl) | 1980-08-29 |
IL58489A0 (en) | 1980-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS211364B2 (en) | Method of making the oxymorfone | |
CA2040927C (fr) | Procede de fabrication de sucrose-6-ester | |
IE911343A1 (en) | Process for recovery of organotin esters from reaction mixtures containing the same and re-use of the recovered organotin compounds | |
JPH0212478B2 (fr) | ||
CN1015104B (zh) | 烯丙基酯类和醚类的脱保护方法 | |
EP0079447B1 (fr) | Dérivés de déazapurine | |
US5256793A (en) | Triazolinone ring formation in tert-butanol | |
US6049014A (en) | Process for the manufacture of tetrabromobisphenol-A with co-production of n-propyl bromide | |
EP0327473A2 (fr) | Procédé de préparation de métaborate d'aryle et son application à la préparation des alcools orthohydroxybenzyliques | |
JP3446899B2 (ja) | ハロピリジル−アザビシクロヘプタン誘導体の製造法および中間体 | |
US5162570A (en) | Process for producing 1,4-dihydroxy-2-arylnaphthoate | |
US5241103A (en) | Process for producing 1,4-dihydroxy-2-arylnaphthoate | |
US5157156A (en) | Process for preparing an intermediate useful in the syntheis of probucol | |
EP0297783B1 (fr) | Méthode de préparation de 4-alcoxyppyridine-1-oxides | |
CA1290754C (fr) | Methode de fabrication des derives de benzoguanamine | |
Hart et al. | Semi-synthesis and insecticidal activity of dyshomoerythrine derivatives | |
CA1134839A (fr) | Preparation de 5-hydroxymethylimidazoles | |
US4709059A (en) | Process for selective halogenation of primary hydroxyl groups | |
EP0062068B1 (fr) | Derives de n-phthalidyl-5-fluorouracile | |
EP0319960B1 (fr) | Dérivé d'imidazole | |
EP0222172A2 (fr) | Dérivé de l'acide N-glycolylneuraminique | |
EP0524959B1 (fr) | Procede d'obtention d'un intermediaire de sultamicilline | |
KR900008126B1 (ko) | 할로겐화 페놀-알데히드 축합생성물 유도체의 제조방법 | |
US20040034213A1 (en) | Process for producing a ribofuranose | |
EP0074837A1 (fr) | Pyridines 4-substitués comme catalyseurs |